Hafez, W.; Ziade, M.A.; Arya, A.; Saleh, H.; Abdelshakor, M.; Fadl Alla, O.; Agrawal, P.; Ali, S.; Rao, S.R.; Gupta, S.;
et al. Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study. Antibiotics 2022, 11, 241.
https://doi.org/10.3390/antibiotics11020241
AMA Style
Hafez W, Ziade MA, Arya A, Saleh H, Abdelshakor M, Fadl Alla O, Agrawal P, Ali S, Rao SR, Gupta S,
et al. Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study. Antibiotics. 2022; 11(2):241.
https://doi.org/10.3390/antibiotics11020241
Chicago/Turabian Style
Hafez, Wael, Mohamad Azzam Ziade, Arun Arya, Husam Saleh, Mahmoud Abdelshakor, Osman Fadl Alla, Pragati Agrawal, Sara Ali, Srinivasa Raghu Rao, Subrata Gupta,
and et al. 2022. "Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study" Antibiotics 11, no. 2: 241.
https://doi.org/10.3390/antibiotics11020241
APA Style
Hafez, W., Ziade, M. A., Arya, A., Saleh, H., Abdelshakor, M., Fadl Alla, O., Agrawal, P., Ali, S., Rao, S. R., Gupta, S., Abdelli, I., Sebastian, H., Ali, M., Gador, M., Al Baha, Z., & Abdelrahman, A.
(2022). Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study. Antibiotics, 11(2), 241.
https://doi.org/10.3390/antibiotics11020241
